Position in HROW
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,337,208
+$799,459 QoQ
Shares Held
31,486
+106.5% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 223 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. HROW ranks #28 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,809,278 | $130,014,715 | |
| 2 | HLN |
Haleon plc
|
4,924,330 | $45,943,997 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
253,026 | $42,644,999 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
74,303 | $40,259,592 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
976,361 | $24,028,242 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
559,389 | $19,394,014 | |
| 7 | VTRS |
Viatris Inc
|
1,175,495 | $18,666,859 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,150,820 | $18,447,643 |
All Filings in HROW
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,337,208 | 31,486 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $537,749 | 15,251 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,916,488 | 39,112 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,179,444 | 24,480 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $552,406 | 18,088 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $398,334 | 14,975 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $478,792 | 14,271 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $783,291 | 17,422 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $739,546 | 35,402 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $120,128 | 9,080 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $88,099 | 7,866 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $84,409 | 5,874 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $206,907 | 10,867 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,306,121 | 61,726 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $9,903 | 671 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,015 | 167 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,186 | 163 | Shares | Defined | 2022-08-12 | |
| 2021-09-30 | $1,345 | 148 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $60,394 | 6,501 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,924,194 | 285,066 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $628,945 | 91,683 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $341,660 | 61,120 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $240,326 | 46,128 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $127,293 | 33,323 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||